All Editorial articles – Page 69
-
NewsExcessive use of disinfectants in intensive care patients may increase the risk of antibiotic-resistant infections
An international study has, for the first time, revealed a strong and direct link between the rise of antibiotic-resistant bacteria and universal disinfection procedures applied to patients in intensive care units.
-
NewsAFYREN begins new phase of industrial strategy as first plant AFYREN NEOXY achieves continuous production
Greentech company AFYREN offering industrial customers bio-based, low-carbon products through fermentation technology based on a circular model, announced its first plant has achieved continuous production, enabling acceleration of commercialization.
-
NewsGut microbes may help in recognizing and treating pancreatic cancer
A new international cooperation study indicates that in the future pancreatic cancer may be detected at an early stage with the help of gut microbes. Gut microbes may also offer solutions for therapy development.
-
NewsStudy highlights role of jaundice-associated pigment in protecting against malaria
New research suggests that a pigment that causes yellowing of the skin, or jaundice, may help protect people from the most severe consequences of malaria.
-
NewsBroad-spectrum coronavirus drug developed through AI-enabled dynamic modeling
Multidisciplinary AI- and physics-driven modeling of the viral fusion process enables discovery of an orally available drug inhibiting infection with multiple coronaviruses.
-
NewsScientists discover the ‘ticking’ mechanism driving nature’s simplest circadian clock
Researchers have uncovered the molecular mechanism that drives the ’ticking’ of the circadian clock in cyanobacteria. A clock protein called KaiC controls chemical reactions with precision, acting like the hand of a clock that waits, then moves at just the right moment.
-
NewsResearchers discover protein necessary for SARS-CoV-2 to evade the body’s defenses
Researchers have identified a protein that plays a key role in helping SARS-CoV-2 hide from the body’s defenses by suppressing the production of viral double-stranded (dsRNA), leading to increased viral replication while limiting the body’s immune response.
-
NewsNorthward jet stream shift hits phytoplankton in the Mediterranean Sea
In just over 20 years, the northward shift of the subtropical jet stream — a high-altitude airflow — caused by climate change has reduced primary production in the northwestern Mediterranean by about 40%, affecting the base of the marine food web.
-
News'Both diagnostic and therapeutic use of the microbiota will become reality within the next 5-10 years'
A new article summarizes results of research and possible future clinical applications of the microbiome and provides instructions for doctors.
-
NewsEvolutionary model for antibiotic resistance reveals dose timing critical to care
The study that uses a “fitness seascape” to incorporate a patient’s dosage schedule into models that predict whether an infection will develop antibiotic resistance has found that inconsistent timing and missing early doses can lead to treatment failure.
-
NewsMicrobiome stability shapes how corals withstand extreme heat
A new study reveals why some corals resist bleaching while others don’t: the answer lies in a complex partnership between corals and their microbial allies, shaped by the history of the waters they inhabit.
-
NewsOxymatrine, a quinoline alkaloid derived from Sophora flavescens, inhibits the Malassezia biofilm
Oxymatrine not only controls Malassezia overgrowth but also manages psoriasis symptoms, offering a dual-action mechanism for safer and more effective therapy, a new study shows.
-
NewsGlobal action urgently needed to tackle antimicrobial resistance, experts warn
Scientists have called for urgent changes to the way new antibiotics are developed to address the growing problem of antimicrobial resistance (AMR). They outline the scientific, economic, and regulatory barriers that are slowing progress.
-
NewsScientists develop a treatment platform to disable the ‘biofilm’ shield of superbugs
Researchers have developed a platform that utilizes microbubbles to deliver gene-targeted nanoparticles capable of breaking down MRSA biofilms, offering an innovative solution for treating infections resistant to conventional antibiotics.
-
NewsResearchers identify new llama-derived antibodies against current and future coronaviruses
Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous early and recent SARS-CoV-2 variants.
-
NewsFusobacterium nucleatum in colorectal cancer: Ally mechanism and targeted therapy strategies
A recent review systematically outlines the pathogenic mechanisms of Fusobacterium nucleatum in colorectal cancer and summarizes both current and emerging strategies for its therapeutic targeting.
-
NewsGeneXpert MTB/RIF technology can distinguish non-tuberculous mycobacterial infection
Xpert Mycobacterium tuberculosis/rifampicin (Xpert MTB/RIF) in alveolar lavage fluid can not only detect rifampicin resistance but also distinguish pulmonary tuberculosis (TB) from non-tuberculosis mycobacterial (NTM) pulmonary disease.
-
NewsEpidemiological trends and serological profiles of respiratory pathogens in Guangzhou
A new study analyzing the epidemiological trends of multiple respiratory pathogens in Guangzhou, China, from 2013 to 2023, indicates the need for age- and gender-specific approaches to infection prevention and management.
-
NewsProbiotic breakthrough: Bifidobacterium animalis subsp. Lactis A6 shows promise in alleviating comorbid constipation and depression
A new study clarifies how gut microbes influence mental health and offers a safe, targeted probiotic therapy, Bifidobacterium animalis subsp. Lactis A6 (BBA6), for comorbid constipation and depression.
-
NewsCan a psychedelic compound from mushrooms benefit people with cancer and major depression?
New results from a clinical trial reveal that a single dose of psilocybin—a naturally occurring psychedelic compound found in mushrooms—can provide sustained reductions in depression and anxiety in individuals with cancer suffering from major depressive disorder.